Endometrial regenerative cells with galectin-9 high-expression attenuate experimental autoimmune hepatitis.
Hongda WangYiming ZhaoBingbing RenYafei QinGuangming LiDejun KongHong QinJingpeng HaoDaqing SunHao WangPublished in: Stem cell research & therapy (2021)
The results suggested that Gal-9 was an essential modulator, which was required by ERCs in regulating T cell response and attenuating ConA-induced experimental hepatitis. And also, it provides a novel idea for the clinical treatment of AIH.